Literature DB >> 20008325

The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity.

Julienne R Escamilla-Powers1, Colin J Daniel, Amy Farrell, Karyn Taylor, Xiaoli Zhang, Sarah Byers, Rosalie Sears.   

Abstract

c-Myc is an important transcription factor that regulates cellular proliferation, cell growth, and differentiation. A number of transcriptional co-factors for c-Myc have been described that have binding sites within highly conserved regions of the c-Myc transactivational domain (TAD). Given the importance of the c-Myc TAD, we set out to identify new proteins that interact with this region using a yeast two-hybrid assay. HBP1 was identified in our screen as a protein that interacts with full-length c-Myc but not a c-Myc mutant lacking the TAD. HBP1 is a transcriptional repressor and has been shown to negatively regulate the cell cycle. A correlation between HBP1 under-expression and breast cancer relapse has been described, suggesting that HBP1 may be an important tumor suppressor protein. We have found that HBP1 binds c-Myc in cells, and expression of HBP1 inhibits c-Myc transactivational activity at least partly by preventing c-Myc binding to target gene promoters. c-Myc binds to the C terminus of HBP1, a region lost in some breast tumors, and some HBP1 mutants found in breast cancer weakly interact with and/or no longer negatively regulate c-Myc. This work adds to our understanding of c-Myc regulation and mechanisms of tumor suppression by HBP1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008325      PMCID: PMC2836090          DOI: 10.1074/jbc.M109.074856

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family.

Authors:  S G Tevosian; H H Shih; K G Mendelson; K A Sheppard; K E Paulson; A S Yee
Journal:  Genes Dev       Date:  1997-02-01       Impact factor: 11.361

2.  The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A.

Authors:  P Lavender; L Vandel; A J Bannister; T Kouzarides
Journal:  Oncogene       Date:  1997-06-05       Impact factor: 9.867

3.  An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc.

Authors:  R M Jones; J Branda; K A Johnston; M Polymenis; M Gadd; A Rustgi; L Callanan; E V Schmidt
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  Cdc25 cell-cycle phosphatase as a target of c-myc.

Authors:  K Galaktionov; X Chen; D Beach
Journal:  Nature       Date:  1996-08-08       Impact factor: 49.962

5.  Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.

Authors:  P J Hurlin; C Quéva; R N Eisenman
Journal:  Genes Dev       Date:  1997-01-01       Impact factor: 11.361

6.  Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis.

Authors:  B Lutterbach; S R Hann
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  Expression cloning in K+ transport defective yeast and distribution of HBP1, a new putative HMG transcriptional regulator.

Authors:  F Lesage; J P Hugnot; E Z Amri; P Grimaldi; J Barhanin; M Lazdunski
Journal:  Nucleic Acids Res       Date:  1994-09-11       Impact factor: 16.971

8.  Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene.

Authors:  J C Zenklusen; J C Thompson; A J Klein-Szanto; C J Conti
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

9.  Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.

Authors:  D E Ayer; Q A Lawrence; R N Eisenman
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

10.  Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.

Authors:  J C Zenklusen; J N Weitzel; H G Ball; C J Conti
Journal:  Oncogene       Date:  1995-07-20       Impact factor: 9.867

View more
  20 in total

1.  ALK positively regulates MYCN activity through repression of HBP1 expression.

Authors:  Shana Claeys; Geertrui Denecker; Kaat Durinck; Bieke Decaesteker; Liselot M Mus; Siebe Loontiens; Suzanne Vanhauwaert; Kristina Althoff; Caroline Wigerup; Daniel Bexell; Emmy Dolman; Kai-Oliver Henrich; Lea Wehrmann; Ellen M Westerhout; Jean-Baptiste Demoulin; Candy Kumps; Tom Van Maerken; Genevieve Laureys; Christophe Van Neste; Bram De Wilde; Olivier De Wever; Frank Westermann; Rogier Versteeg; Jan J Molenaar; Sven Påhlman; Johannes H Schulte; Katleen De Preter; Frank Speleman
Journal:  Oncogene       Date:  2018-12-11       Impact factor: 9.867

2.  MiR-29a modulates the angiogenic properties of human endothelial cells.

Authors:  Zeran Yang; Lingjiao Wu; Xiuming Zhu; Jie Xu; Rong Jin; Guohong Li; Fusheng Wu
Journal:  Biochem Biophys Res Commun       Date:  2013-03-28       Impact factor: 3.575

3.  Immunohistochemical and genetic markers to distinguish hemangiopericytoma and meningioma.

Authors:  Penglai Zhao; Tongming Zhu; Qisheng Tang; Hongyi Liu; Jianhong Zhu; Wenbin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  HBP1-mediated transcriptional regulation of DNA methyltransferase 1 and its impact on cell senescence.

Authors:  Kewu Pan; Yifan Chen; Mendel Roth; Weibin Wang; Shuya Wang; Amy S Yee; Xiaowei Zhang
Journal:  Mol Cell Biol       Date:  2012-12-17       Impact factor: 4.272

5.  Ribosomal protein S14 negatively regulates c-Myc activity.

Authors:  Xiang Zhou; Qian Hao; Jun-Ming Liao; Peng Liao; Hua Lu
Journal:  J Biol Chem       Date:  2013-06-17       Impact factor: 5.157

6.  TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.

Authors:  Ken-ichi Takayama; Aya Misawa; Takashi Suzuki; Kiyoshi Takagi; Yoshihide Hayashizaki; Tetsuya Fujimura; Yukio Homma; Satoru Takahashi; Tomohiko Urano; Satoshi Inoue
Journal:  Nat Commun       Date:  2015-09-25       Impact factor: 14.919

Review 7.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 8.  The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways.

Authors:  Emeline Bollaert; Audrey de Rocca Serra; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.261

9.  Acetylation of human TCF4 (TCF7L2) proteins attenuates inhibition by the HBP1 repressor and induces a conformational change in the TCF4::DNA complex.

Authors:  Susanne Elfert; Andreas Weise; Katja Bruser; Martin L Biniossek; Sabine Jägle; Niklas Senghaas; Andreas Hecht
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

10.  MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition.

Authors:  A J DeCastro; K A Dunphy; J Hutchinson; A L Balboni; P Cherukuri; D J Jerry; J DiRenzo
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.